150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

NCT07346235 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
440
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

American Hospital 2 Kosovo